| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SNCG |
| Uniprot No | O76070 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-127aa |
| 氨基酸序列 | MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGAKTKENVVQSVTSVAEKTKEQANAVSEAVVSSVNTVATKTVEEAENIAVTSGVVRKEDLRPSAPQQEGEASKEKEEVAEEAQSGGD |
| 预测分子量 | 29.3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SNCG(Stathmin-2/SCG10)重组蛋白的3篇参考文献的简要整理：
1. **文献名称**：*"Stathmin overexpression identifies ovarian carcinomas with poor prognosis"*
**作者**：Chen Y. et al.
**摘要**：研究通过重组SNCG蛋白实验，发现其在卵巢癌中高表达与患者预后不良相关，可能通过促进微管动态性增强肿瘤侵袭能力。
2. **文献名称**：*"SCG10 promotes tumor metastasis via ERK/MMP signaling in hepatocellular carcinoma"*
**作者**：Li H. et al.
**摘要**：利用重组SNCG蛋白验证其在肝癌细胞中的作用，发现其通过激活ERK/MMP通路促进癌细胞迁移和转移，敲低SNCG可抑制体内外转移。
3. **文献名称**：*"Recombinant stathmin-2 disrupts microtubule dynamics and sensitizes breast cancer cells to paclitaxel"*
**作者**：Wang X. et al.
**摘要**：研究在大肠杆菌中表达纯化SNCG重组蛋白，发现其与紫杉醇竞争结合微管，破坏微管稳定性，可能作为化疗增敏剂的应用潜力。
注：SNCG相关研究常聚焦于其微管调控功能与肿瘤进展的关联。实际文献需根据具体研究目标通过PubMed/Google Scholar检索，关键词如“recombinant SNCG protein”或“stathmin-2 cancer”。
SNCG (Synuclein Gamma), also known as γ-synuclein, is a member of the synuclein protein family that includes α-synuclein (implicated in neurodegenerative disorders) and β-synuclein. Primarily expressed in the nervous system, SNCG has gained attention for its aberrant overexpression in various cancers, including breast, ovarian, and liver carcinomas. Unlike its familial counterparts, SNCG lacks direct links to neurodegeneration but is associated with tumor progression, metastasis, and poor prognosis. Its oncogenic role involves interactions with signaling pathways like PI3K/AKT and ERK, promoting cell proliferation, invasion, and chemoresistance.
Recombinant SNCG protein is produced using biotechnological platforms (e.g., E. coli or mammalian expression systems) to enable functional studies. Purification typically involves affinity chromatography followed by refolding steps to ensure proper conformation. As a research tool, recombinant SNCG facilitates investigations into its structure-function relationships, post-translational modifications, and pathological mechanisms. It serves as an antigen for antibody development in diagnostic assays and potential targeted therapies. Challenges include its intrinsically disordered nature, which complicates structural analysis, and context-dependent roles in different cancer types. Current research focuses on elucidating its extracellular roles in tumor microenvironment modulation and exploring its utility as a biomarker or therapeutic target.
×
